<DOC>
	<DOCNO>NCT00564226</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy SSR240600C woman overactive bladder compare placebo use tolterodine study calibrator .</brief_summary>
	<brief_title>SSR240600C Treatment Women With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Diagnosis overactive bladder Stress incontinence mix incontinence stress incontinence predominant component base prior history Urinary incontinence due cause detrusor overactivity ( eg , overflow incontinence ) Current Urinary Tract Infection ( UTI ) frequent UTIs Urinary retention evidence poor detrusor function Pain void bladder pain without void History radiation cystitis history pelvic irradiation History interstitial cystitis bladder relate pain syndrome The information intend contain consideration relevant participant 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>urge urinary incontinence</keyword>
</DOC>